178 related articles for article (PubMed ID: 29753123)
1. Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for wet age-related macular degeneration: A systematic review and meta-analysis.
Su Y; Wu J; Gu Y
Photodiagnosis Photodyn Ther; 2018 Jun; 22():263-273. PubMed ID: 29753123
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis.
Liu L; Tham YC; Wu J; Yue S; Cheng CY
Photodiagnosis Photodyn Ther; 2017 Dec; 20():215-220. PubMed ID: 28935532
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.
Ba J; Peng RS; Xu D; Li YH; Shi H; Wang Q; Yu J
Drug Des Devel Ther; 2015; 9():5397-405. PubMed ID: 26451092
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study.
Kaiser PK; Boyer DS; Cruess AF; Slakter JS; Pilz S; Weisberger A;
Ophthalmology; 2012 May; 119(5):1001-10. PubMed ID: 22444829
[TBL] [Abstract][Full Text] [Related]
5. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results.
Larsen M; Schmidt-Erfurth U; Lanzetta P; Wolf S; Simader C; Tokaji E; Pilz S; Weisberger A;
Ophthalmology; 2012 May; 119(5):992-1000. PubMed ID: 22424834
[TBL] [Abstract][Full Text] [Related]
6. Predictors of 1-year visual outcome in OCT analysis comparing ranibizumab monotherapy versus combination therapy with PDT in exsudative age-related macular degeneration.
Weingessel B; Mihaltz K; Vécsei-Marlovits PV
Wien Klin Wochenschr; 2016 Aug; 128(15-16):560-5. PubMed ID: 25787216
[TBL] [Abstract][Full Text] [Related]
7. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
Spielberg L; Leys A
Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
[TBL] [Abstract][Full Text] [Related]
8. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
Kourlas H; Abrams P
Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
[TBL] [Abstract][Full Text] [Related]
9. A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
Sivaprasad S; Patra S; DaCosta J; Adewoyin T; Shona O; Pearce E; Chong NV
Ophthalmologica; 2011; 225(4):200-6. PubMed ID: 21293163
[TBL] [Abstract][Full Text] [Related]
10. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
[TBL] [Abstract][Full Text] [Related]
11. TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH RANIBIZUMAB COMBINED WITH KETOROLAC EYEDROPS OR PHOTODYNAMIC THERAPY.
Semeraro F; Russo A; Delcassi L; Romano MR; Rinaldi M; Chiosi F; Costagliola C
Retina; 2015 Aug; 35(8):1547-54. PubMed ID: 25784358
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF Monotherapy Versus Photodynamic Therapy and Anti-VEGF Combination Treatment for Neovascular Age-Related Macular Degeneration: A Meta-Analysis.
Gao Y; Yu T; Zhang Y; Dang G
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4307-4317. PubMed ID: 30372759
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Seidel G; Werner C; Weger M; Steinbrugger I; Haas A
Acta Ophthalmol; 2013 Sep; 91(6):e482-5. PubMed ID: 23786546
[TBL] [Abstract][Full Text] [Related]
14. Combination of ranibizumab with photodynamic therapy vs ranibizumab monotherapy in the treatment of age-related macular degeneration: a systematic review and meta-analysis of randomized controlled trials.
Si JK; Tang K; Bi HS; Guo DD; Guo JG; Du YX; Cui Y; Pan XM; Wen Y; Wang XR
Int J Ophthalmol; 2014; 7(3):541-9. PubMed ID: 24967206
[TBL] [Abstract][Full Text] [Related]
15. Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
Bressler NM; Chang TS; Varma R; Suñer I; Lee P; Dolan CM; Ward J; Ianchulev T; Fine J
Ophthalmology; 2013 Jan; 120(1):160-8. PubMed ID: 23009891
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Ranibizumab monotherapy versus combination of Ranibizumab with photodynamic therapy with neovascular age-related macular degeneration.
Krebs I; Vécsei Marlovits V; Bodenstorfer J; Glittenberg C; Ansari Shahrezaei S; Ristl R; Binder S
Acta Ophthalmol; 2013 May; 91(3):e178-83. PubMed ID: 23241227
[TBL] [Abstract][Full Text] [Related]
17. Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
Saito M; Iida T; Kano M
Am J Ophthalmol; 2012 Mar; 153(3):504-514.e1. PubMed ID: 22078902
[TBL] [Abstract][Full Text] [Related]
18. Clinical Efficacy and Safety of Current Interventions for Choroidal Neovascularization Associated with Rare Diseases: A Systematic Literature Review.
Bennett N; John L; Likhar N; Agrawal R; Amoaku WM
Adv Ther; 2018 May; 35(5):591-603. PubMed ID: 29687336
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
Shi X; Wei W; Zhang C
Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
[TBL] [Abstract][Full Text] [Related]
20. Comparing ranibizumab monotherapy and combination with single photodynamic therapy in wet AMD: retreatment and morphologic results.
Hatz K; Schneider U; Henrich B; Braun B; Sacu S; Prünte C
Eur J Ophthalmol; 2017 Jun; 27(4):470-475. PubMed ID: 27739558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
